Dapagliflozin

Major

Dapagliflozin Abiraterone Abirtega An increased risk of severe hypoglycemia Details Dapagliflozin Chloroquine Aralen® Hypoglycemia Details Dapagliflozin Abiraterone Acetate Abirtega An increased risk of severe hypoglycemia Details Dapagliflozin Abiraterone Acetate, Micronized Abirtega An increased risk of severe hypoglycemia Details Dapagliflozin Cannabidiol Epidiolex Increased UGT1A9 substrate exposure and an increased risk of UGT1A9 substrate-related adverse reactions Details Dapagliflozin Chlorothiazide Diuril An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Chlorthalidone Hemiclor An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Ciprofloxacin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Delafloxacin Baxdela Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Enoxacin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Furosemide Disal An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Gatifloxacin Zymaxid Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Gemifloxacin Factive Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Grepafloxacin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Hydrochlorothiazide Inzirqo An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Hydroflumethiazide An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Hydroxychloroquine Plaquenil Enhanced hypoglycemic effect of antidiabetics and an increased risk of hypoglycemia Details Dapagliflozin Indapamide An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Insulin Afrezza An increased risk of hypoglycemia Details Dapagliflozin Insulin Aspart, Recombinant Fiasp An increased risk of hypoglycemia Details Dapagliflozin Insulin Bovine An increased risk of hypoglycemia Details Dapagliflozin Insulin Degludec Tresiba An increased risk of hypoglycemia Details Dapagliflozin Insulin Detemir Levemir An increased risk of hypoglycemia Details Dapagliflozin Insulin Glargine, Recombinant Basaglar An increased risk of hypoglycemia Details Dapagliflozin Insulin Glulisine Apidra An increased risk of hypoglycemia Details Dapagliflozin Insulin Icodec-Abae Awiqli An increased risk of hypoglycemia Details Dapagliflozin Insulin Lispro, Recombinant Admelog An increased risk of hypoglycemia Details Dapagliflozin Lanreotide Acetate An increased risk of hypoglycemia and impaired glucose regulation Details Dapagliflozin Levofloxacin Levaquin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Lithium Reduced lithium exposure Details Dapagliflozin Lomefloxacin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Metolazone An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Moxifloxacin Avelox Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Norfloxacin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Octreotide Acetate An increased risk of hypoglycemia and impaired glucose regulation Details Dapagliflozin Ofloxacin Floxin® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Dapagliflozin Pasireotide Diaspartate An increased risk of hypoglycemia and impaired glucose regulation Details Dapagliflozin Polythiazide An increased risk of hyperglycemia and an increased insulin requirement Details Dapagliflozin Pramlintide Symlin An increased risk of hypoglycemia Details Dapagliflozin Somatrogon-Ghla Reduced insulin sensitivity Details